Rallybio Corporation
RLYB
$0.626
$0.0325.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 212.00K | 212.00K | 38.00K | 299.00K | 299.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 212.00K | 212.00K | 38.00K | 299.00K | 299.00K |
| Cost of Revenue | 618.00K | 5.73M | 7.39M | 8.24M | 772.00K |
| Gross Profit | -406.00K | -5.51M | -7.35M | -7.94M | -473.00K |
| SG&A Expenses | 4.20M | 4.16M | 4.26M | 4.13M | 4.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.27M | 9.88M | 11.65M | 12.37M | 17.33M |
| Operating Income | -10.06M | -9.67M | -11.61M | -12.07M | -17.04M |
| Income Before Tax | -9.70M | -9.44M | -11.04M | -11.47M | -16.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.70M | -9.44M | -11.04M | -11.47M | -16.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.70M | -9.44M | -11.04M | -11.47M | -16.24M |
| EBIT | -10.06M | -9.67M | -11.61M | -12.07M | -17.04M |
| EBITDA | -10.03M | -9.64M | -11.58M | -12.03M | -17.00M |
| EPS Basic | -0.22 | -0.21 | -0.25 | -0.26 | -0.37 |
| Normalized Basic EPS | -0.14 | -0.13 | -0.15 | -0.16 | -0.23 |
| EPS Diluted | -0.22 | -0.21 | -0.25 | -0.26 | -0.37 |
| Normalized Diluted EPS | -0.14 | -0.13 | -0.15 | -0.16 | -0.23 |
| Average Basic Shares Outstanding | 44.84M | 44.77M | 44.66M | 44.59M | 44.13M |
| Average Diluted Shares Outstanding | 44.84M | 44.77M | 44.66M | 44.59M | 44.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |